Fesoterodine generic name?

What is the generic name for Fesoterodine?

Fesoterodine, a muscarinic receptor antagonist used to treat overactive bladder, has a generic name that allows its formulation and sale by various pharmaceutical companies. [1]

Can generic versions of Fesoterodine enter the market?

Yes, according to DrugPatentWatch.com, the patent for Toviaz (fesoterodine fumarate), a branded version of Fesoterodine, expires in 2030. [2] However, as with all generic drug developments, it's possible that generic versions of Fesoterodine may be available sooner, subject to regulatory approval and manufacturing compliance.

Is Toviaz the only Fesoterodine formulation available?

No, in addition to Toviaz, fesoterodine is available in a generic formulation, such as in the US market where it's marketed and sold by multiple manufacturers. Fesoterodine is the generic name for the drug, and the variations in branded names, such as Toviaz, are primarily marketing and distribution-related.

What benefits can generic versions of Fesoterodine provide patients?

Generic versions of Fesoterodine may offer several benefits, including lower costs due to reduced research and development expenses. Additionally, generic drugs are subject to the same quality and safety standards as their branded counterparts, ensuring patients receive the same high-quality medication.

References:

[1] MedlinePlus, Fesoterodine Fumarate - Drug monograph. https://medlineplus.gov/druginfo/meds/a613032.html

[2] DrugPatentWatch.com, Fesoterodine Fumarate patent expiration in 2027. https://www.drugpatentwatch.com/compound/fesoterodine-fumarate